Show simple item record

dc.contributor.authorGomceli, Ismail
dc.contributor.authorAkoglu, Musa
dc.contributor.authorKemik, Ahu S.
dc.contributor.authorTurhan, Nesrin
dc.contributor.authorUlas, Murat
dc.contributor.authorBostanci, Erdal B.
dc.contributor.authorTez, Mesut
dc.date.accessioned2021-03-06T11:19:03Z
dc.date.available2021-03-06T11:19:03Z
dc.date.issued2012
dc.identifier.citationGomceli I., Tez M., Bostanci E. B. , Ulas M., Turhan N., Kemik A. S. , Akoglu M., "Is Serum Placental Growth Factor a Prognostic Marker for Stage III Colorectal Cancer Patients?", HEPATO-GASTROENTEROLOGY, cilt.59, ss.1437-1440, 2012
dc.identifier.issn0172-6390
dc.identifier.othervv_1032021
dc.identifier.otherav_ee75b544-9180-4ba4-86be-7fe0d7fa5535
dc.identifier.urihttp://hdl.handle.net/20.500.12627/156539
dc.identifier.urihttps://doi.org/10.5754/hge11393
dc.description.abstractBackground/Aims: To evaluate the clinical usefulness of serum placental growth factor (sPIGF) levels in stage III colorectal adenocarcinomas (CRC). Methodology: Serum PIGF were measured in 70 healthy controls and in 80 stage III CRC patients. Also the association between preoperative sPGF levels, clinicopathological features and patients survival were evaluated in stage III CRC patients. Results: sPIGF levels in stage III CRC patients were significantly higher than those in controls. There was no significant association between sPIGF levels and clinicopathological features and sPIGF is not a prognostic factor for survival. Multivariate regression analysis showed the sPIGF levels (hazard ratio=3.28; 95% CI=1.10-9.5, p=0.032) to be significant independent factors for local recurrence. Conclusions: Serum PIGF levels in stage III CRC patients are significantly higher compared with normal controls and may be an indicator of local recurrence in stage III CRC patients.
dc.language.isoeng
dc.subjectCERRAHİ
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectGASTROENTEROLOJİ VE HEPATOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectİç Hastalıkları
dc.subjectGastroenteroloji-(Hepatoloji)
dc.subjectCerrahi Tıp Bilimleri
dc.titleIs Serum Placental Growth Factor a Prognostic Marker for Stage III Colorectal Cancer Patients?
dc.typeMakale
dc.relation.journalHEPATO-GASTROENTEROLOGY
dc.contributor.departmentTurkey Specialized Higher Education & Research Hospital , ,
dc.identifier.volume59
dc.identifier.issue117
dc.identifier.startpage1437
dc.identifier.endpage1440
dc.contributor.firstauthorID204936


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record